Tag: antiCTLA4
Nanobiotix announces the publication of new preclinical data describing the potential of combining NBTXR3 with anti-PD-1 and anti-CTLA-4 immunotherapies – 01/26/2022 at 22:29
Data published in the International Journal of Nanobiotechnology – New preclinical data (published in a peer-reviewed journal) from a model of anti-PD-1 resistant lung cancer shows that adding NBTXR3 to…